COVAXIN | Page 3 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
    • Energy
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
September 10, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
    • Energy
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, SEPTEMBER 10, 2026

COVAXIN

COVAXIN

Doraiswami keen to push Covaxin as Covishield exports disrupted

Doraiswami keen to push Covaxin as Covishield exports disrupted

The High Commissioner said besides the Covishield vaccine from Serum, the alternative that they have consistently been offering to export Covaxin, which they offered not only for trial here in...

Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states

Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states

NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci addresses the daily press briefing at the White House in Washington, US January 21, 2021. REUTERS/Jonathan Ernst

India's Covaxin found to neutralise '617' variant of Covid-19, says Dr Fauci

Representational Image. Photo: Reuters

Bangladesh not to get any vaccine from India soon: High Commission

Covaxin shot 78% effective against Covid, say developers

Covaxin shot 78% effective against Covid, say developers

Covaxin neutralises double mutant strain: ICMR

Covaxin neutralises double mutant strain: ICMR

Addressing a petroleum university’s convocation, Modi said: “Work is being done to nearly double the country’s oil refining capacity in the next five years” Photo: Collected from Twitter

Narendra Modi gets second dose of Covid vaccine

Covaxin can be taken off 'clinical trial mode', expert panel recommends

Covaxin can be taken off 'clinical trial mode', expert panel recommends

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

Bharat Biotech shot shows high immune response, further study needed for elderly

Covaxin safe, can be stored at 2-8°C, says Lancet report

Covaxin safe, can be stored at 2-8°C, says Lancet report

Covaxin shows interim clinical efficacy of 81% in Phase 3 results

Covaxin shows interim clinical efficacy of 81% in Phase 3 results

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

Modi's ministers choose 'Made in India' vaccine over AstraZeneca

FILE PHOTO: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's Covid-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi

India's COVAXIN likely effective against UK variant - study

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net